Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life.


Biotechnology

Epsilogen

Epsilogen's headquarters in London, United Kingdom

This department focuses on conducting scientific research and developing innovative solutions.

Research and Development

The Scientific Team at Epsilogen focuses on the research and development of immunoglobulin (IgE) antibodies for cancer treatment. Team members collaborate to design, engineer, and optimize potent IgE antibodies, leveraging their expertise in phage display, protein science, and advanced scientific methodologies to enhance tumour targeting and improve therapeutic efficacy.

Scientific Team

The Leadership Team at Epsilogen is responsible for setting the strategic direction of the company, overseeing research and development efforts in immunoglobulin (IgE) antibodies for cancer treatment. They collaborate to drive innovation, ensure effective product development, and navigate the organization toward achieving its mission of revolutionizing cancer therapies. With a focus on leveraging IgE's unique properties, the team works to enhance clinical outcomes and accelerate the path to market.

Leadership Team

This department manages relationships and communications between the organization and its board members.

Board Relations

This department oversees the strategic direction and leadership in medical and translational science initiatives.

Medical Leadership

This department manages office operations and coordinates various projects to ensure organizational efficiency.

People (4)

Jobs (0)

Other teams

Scientific Team

Leadership Team

Board Relations

Medical Leadership

Administrative Services